Use of centrally developed pharmacoeconomic assessments for local formulary decisions
- 1 September 2006
- journal article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 63 (17) , 1613-1618
Abstract
Purpose. The distribution, content, timeliness, use, and influence of pharmacoeconomic assessments (PEAs) of drugs in New Zealand public hospitals were examined.Keywords
This publication has 15 references indexed in Scilit:
- Managing Prices for Hospital Pharmaceuticals: A Successful Strategy for New Zealand?Value in Health, 2005
- Processes for the Assessment and Introduction of New Medicines in New Zealand HospitalsJournal of Pharmacy Practice and Research, 2004
- What constitutes evidence in hospital new drug decision making?Social Science & Medicine, 2004
- A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey.International Journal of Clinical Pharmacy, 2003
- Pharmacoeconomics: Challenges in Developing the Fourth Dimension of Drug EvaluationJournal of Pharmacy Practice and Research, 2003
- Use of pharmacoeconomic data in making hospital formulary decisionsAmerican Journal of Health-System Pharmacy, 2002
- Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health AuthoritiesValue in Health, 2002
- Economic evaluation under managed competition: Evidence from the U.K.Social Science & Medicine, 1997
- Drug and Therapeutics Committees in Australia: expected and actual performanceBritish Journal of Clinical Pharmacology, 1996
- Towards the safer use of medicinesBMJ, 1995